Lisata Therapeutics, Inc. (LSTA)
1.21
-0.07
(-5.47%)
USD |
NASDAQ |
Nov 13, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 19:59
Lisata Therapeutics Total Assets (Quarterly) : 648.41M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 648.41M |
| June 30, 2026 | 11.03M |
| March 31, 2026 | 14.06M |
| December 31, 2025 | 17.74M |
| September 30, 2025 | 21.76M |
| June 30, 2025 | 25.16M |
| March 31, 2025 | 28.98M |
| December 31, 2024 | 35.00M |
| September 30, 2024 | 38.20M |
| June 30, 2024 | 42.57M |
| March 31, 2024 | 48.24M |
| December 31, 2023 | 54.69M |
| September 30, 2023 | 58.09M |
| June 30, 2023 | 62.36M |
| March 31, 2023 | 66.33M |
| December 31, 2022 | 73.03M |
| September 30, 2022 | 78.53M |
| June 30, 2022 | 85.88M |
| March 31, 2022 | 91.46M |
| December 31, 2021 | 97.01M |
| September 30, 2021 | 102.54M |
| June 30, 2021 | 108.61M |
| March 31, 2021 | 114.61M |
| December 31, 2020 | 36.00M |
| September 30, 2020 | 42.02M |
| Date | Value |
|---|---|
| June 30, 2020 | 37.48M |
| March 31, 2020 | 22.14M |
| December 31, 2019 | 27.15M |
| September 30, 2019 | 31.67M |
| June 30, 2019 | 36.35M |
| March 31, 2019 | 41.29M |
| December 31, 2018 | 44.58M |
| September 30, 2018 | 47.85M |
| June 30, 2018 | 52.09M |
| March 31, 2018 | 56.72M |
| December 31, 2017 | 63.38M |
| September 30, 2017 | 67.56M |
| June 30, 2017 | 72.25M |
| March 31, 2017 | 48.53M |
| December 31, 2016 | 53.51M |
| September 30, 2016 | 57.28M |
| June 30, 2016 | 56.71M |
| March 31, 2016 | 63.18M |
| December 31, 2015 | 57.21M |
| September 30, 2015 | 119.70M |
| June 30, 2015 | 128.62M |
| March 31, 2015 | 118.81M |
| December 31, 2014 | 126.28M |
| September 30, 2014 | 131.34M |
| June 30, 2014 | 133.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.810B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 630.10M |
| Shareholders Equity (Quarterly) | 7.643M |
| Debt to Equity Ratio | 75.29 |
| Current Ratio | 14.09 |
| Net Debt Paydown Yield | -739.7% |